Brineura launch price annual 2017 702000?

Yes. At its 2017 launch, Brineura (cerliponase alfa) had an approximate annual list price of $702,000.

Note: this is the list price. Actual costs to patients can vary based on insurance, rebates, and patient assistance programs. If you’d like, I can share sources or look up how the price has changed since launch.